Home » NPS Pharmaceuticals Drug for Rare Bowel Condition Meets Goals in Testing
NPS Pharmaceuticals Drug for Rare Bowel Condition Meets Goals in Testing
NPS Pharmaceuticals Inc. said its experimental therapy, Gattex, helped restore normal intestinal function in patients with a rare bowel condition in a study, clearing the way to apply for regulatory approval.
Bloomberg
Bloomberg
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May